🟢 Lantern Pharma is trading 6% up today as it extends rebound from recent sharp selloff

Lantern Pharma is trading 6% up today at $3.55, extending its recovery following significant volatility earlier in the week.

• The move follows an 8.06% gain on July 9, which helped offset a sharp 13.17% decline recorded on July 8.
• No new company-specific news or analyst actions have been reported to justify the current price swing.
• The upward momentum appears to be driven by technical factors rather than fresh fundamental developments.